23293020|t|Levels of soluble apolipoprotein E/amyloid-beta (Abeta) complex are reduced and oligomeric Abeta increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
23293020|a|Human apolipoprotein E (apoE) isoforms may differentially modulate amyloid-beta (Abeta) levels. Evidence suggests physical interactions between apoE and Abeta are partially responsible for these functional effects. However, the apoE/Abeta complex is not a single static structure; rather, it is defined by detection methods. Thus, literature results are inconsistent and difficult to interpret. An ELISA was developed to measure soluble apoE/Abeta in a single, quantitative method and was used to address the hypothesis that reduced levels of soluble apoE/Abeta and an increase in soluble Abeta, specifically oligomeric Abeta (oAbeta), are associated with APOE4 and AD. Previously, soluble Abeta42 and oAbeta levels were greater with APOE4 compared with APOE2/APOE3 in hippocampal homogenates from EFAD transgenic mice (expressing five familial AD mutations and human apoE isoforms). In this study, soluble apoE/Abeta levels were lower in E4FAD mice compared with E2FAD and E3FAD mice, thus providing evidence that apoE/Abeta levels isoform-specifically modulate soluble oAbeta clearance. Similar results were observed in soluble preparations of human cortical synaptosomes; apoE/Abeta levels were lower in AD patients compared with controls and lower with APOE4 in the AD cohort. In human CSF, apoE/Abeta levels were also lower in AD patients and with APOE4 in the AD cohort. Importantly, although total Abeta42 levels decreased in AD patients compared with controls, oAbeta levels increased and were greater with APOE4 in the AD cohort. Overall, apoE isoform-specific formation of soluble apoE/Abeta modulates oAbeta levels, suggesting a basis for APOE4-induced AD risk and a mechanistic approach to AD biomarkers.
23293020	18	34	apolipoprotein E	Gene	348
23293020	35	47	amyloid-beta	Gene	351
23293020	49	54	Abeta	Gene	351
23293020	91	96	Abeta	Gene	351
23293020	112	117	APOE4	Gene	348
23293020	122	139	Alzheimer disease	Disease	MESH:D000544
23293020	156	161	mouse	Species	10090
23293020	172	177	human	Species	9606
23293020	187	192	Human	Species	9606
23293020	193	209	apolipoprotein E	Gene	348
23293020	211	215	apoE	Gene	348
23293020	254	266	amyloid-beta	Gene	351
23293020	268	273	Abeta	Gene	351
23293020	331	335	apoE	Gene	348
23293020	340	345	Abeta	Gene	351
23293020	415	419	apoE	Gene	348
23293020	420	425	Abeta	Gene	351
23293020	624	628	apoE	Gene	348
23293020	629	634	Abeta	Gene	351
23293020	738	742	apoE	Gene	348
23293020	743	748	Abeta	Gene	11820
23293020	776	781	Abeta	Gene	11820
23293020	807	812	Abeta	Gene	11820
23293020	843	848	APOE4	Gene	348
23293020	853	855	AD	Disease	MESH:D000544
23293020	877	884	Abeta42	Gene	351
23293020	921	926	APOE4	Gene	348
23293020	985	989	EFAD	Disease	
23293020	1001	1005	mice	Species	10090
23293020	1032	1034	AD	Disease	MESH:D000544
23293020	1049	1054	human	Species	9606
23293020	1055	1059	apoE	Gene	348
23293020	1094	1098	apoE	Gene	348
23293020	1099	1104	Abeta	Gene	11820
23293020	1132	1136	mice	Species	10090
23293020	1167	1171	mice	Species	10090
23293020	1202	1206	apoE	Gene	348
23293020	1207	1212	Abeta	Gene	11820
23293020	1333	1338	human	Species	9606
23293020	1362	1366	apoE	Gene	348
23293020	1367	1372	Abeta	Gene	351
23293020	1394	1396	AD	Disease	MESH:D000544
23293020	1397	1405	patients	Species	9606
23293020	1444	1449	APOE4	Gene	348
23293020	1457	1459	AD	Disease	MESH:D000544
23293020	1471	1476	human	Species	9606
23293020	1482	1486	apoE	Gene	348
23293020	1487	1492	Abeta	Gene	351
23293020	1519	1521	AD	Disease	MESH:D000544
23293020	1522	1530	patients	Species	9606
23293020	1540	1545	APOE4	Gene	348
23293020	1553	1555	AD	Disease	MESH:D000544
23293020	1592	1599	Abeta42	Gene	351
23293020	1620	1622	AD	Disease	MESH:D000544
23293020	1623	1631	patients	Species	9606
23293020	1702	1707	APOE4	Gene	348
23293020	1715	1717	AD	Disease	MESH:D000544
23293020	1735	1739	apoE	Gene	348
23293020	1778	1782	apoE	Gene	348
23293020	1783	1788	Abeta	Gene	351
23293020	1837	1842	APOE4	Gene	348
23293020	1851	1853	AD	Disease	MESH:D000544
23293020	1889	1891	AD	Disease	MESH:D000544
23293020	Positive_Correlation	11820	348
23293020	Association	MESH:D000544	351
23293020	Association	MESH:D000544	348
23293020	Association	MESH:D000544	11820
23293020	Positive_Correlation	348	351

